Terms: = Breast cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76
73309 results:
1. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
[TBL] [Abstract] [Full Text] [Related]
2. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
3. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
4. International Survey of Psychosocial Care for cancer Survivors in Low-/Middle- and High-Income Countries: Current Practices, Barriers, and Facilitators to Care.
Signorelli C; Høeg BL; Asuzu C; Centeno I; Estapé T; Fisher P; Lam W; Levkovich I; Manne S; Miles A; Mullen L; Nekhlyudov L; Sade C; Shaw J; Singleton A; Travado L; Tsuchiya M; Lemmen J; Li J; Jefford M;
JCO Glob Oncol; 2024 May; 10():e2300418. PubMed ID: 38781550
[TBL] [Abstract] [Full Text] [Related]
5. cancer Treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
6. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract] [Full Text] [Related]
7. Reporting on patient's body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review.
Van Cauwenberge J; Van Baelen K; Maetens M; Geukens T; Nguyen HL; Nevelsteen I; Smeets A; Deblander A; Neven P; Koolen S; Wildiers H; Punie K; Desmedt C
Breast Cancer Res; 2024 May; 26(1):81. PubMed ID: 38778365
[TBL] [Abstract] [Full Text] [Related]
8. Effect of combination of Beta Glucan and Lactobacillus rhamnosus HerizI on white blood cell counts and serum levels of IL-4 and IL-12 in women with breast cancer undergoing chemotherapy: A randomized double-blind placebo-controlled clinical trial.
Ostadrahimi A; Ahmadikhatir S; Amirazad H; EivaziZiaei J; AsghariJafarabadi M; Barzeghari A; Esfahani A; Farrin N
Clin Nutr ESPEN; 2024 Jun; 61():281-287. PubMed ID: 38777445
[TBL] [Abstract] [Full Text] [Related]
9. [Adequacy of provision of procedures for early detection of breast cancer in the Brazilian Unified National Health System: a cross-sectional study conducted in Brazil and its regions, 2019].
Dias MBK; Assis M; Santos ROMD; Ribeiro CM; Migowski A; Tomazelli JG
Cad Saude Publica; 2024; 40(5):e00139723. PubMed ID: 38775611
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing breast Conservative Treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
[TBL] [Abstract] [Full Text] [Related]
11. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
12. Infrared laser moxibustion for cancer-related fatigue in breast cancer survivors: a randomized controlled trial.
Mao H; Jin M; Xie L; Mao N; Shen X; Chen J; Chen X; Mao JJ; Shen X
Breast Cancer Res; 2024 May; 26(1):80. PubMed ID: 38773552
[TBL] [Abstract] [Full Text] [Related]
13. Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients.
Kraehenbuehl L; Kang D; Bang AS; Ketosugbo KF; Hay J; Patil S; Goldfarb S; Cho J; Lacouture ME
Support Care Cancer; 2024 May; 32(6):369. PubMed ID: 38773008
[TBL] [Abstract] [Full Text] [Related]
14. Performance of Diffusion-weighted Imaging-based Noncontrast MRI Protocols for Diagnosis of breast cancer: A Systematic Review and Meta-Analysis.
Pötsch N; Sodano C; Baltzer PAT
Radiology; 2024 May; 311(2):e232508. PubMed ID: 38771179
[TBL] [Abstract] [Full Text] [Related]
15. Patient Characteristics Impact Performance of AI Algorithm in Interpreting Negative Screening Digital breast Tomosynthesis Studies.
Nguyen DL; Ren Y; Jones TM; Thomas SM; Lo JY; Grimm LJ
Radiology; 2024 May; 311(2):e232286. PubMed ID: 38771177
[TBL] [Abstract] [Full Text] [Related]
16. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
[TBL] [Abstract] [Full Text] [Related]
18. Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2- metastatic breast cancer: A single center real-world study in China.
Jiang H; Zhong J; Wang J; Song G; Di L; Shao B; Zhang R; Liu Y; Zhu A; Wang N; Li H
Cancer Med; 2024 May; 13(10):e7249. PubMed ID: 38770648
[TBL] [Abstract] [Full Text] [Related]
19. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
[TBL] [Abstract] [Full Text] [Related]
20. Risk Factors and Mortality Among Women With Interval breast cancer vs Screen-Detected breast cancer.
Song H; Tran TXM; Kim S; Park B
JAMA Netw Open; 2024 May; 7(5):e2411927. PubMed ID: 38767918
[TBL] [Abstract] [Full Text] [Related]
[Next]
